NLSP: NLS Pharmaceutics AG Stock

by  •  • Comments Off on NLSP: NLS Pharmaceutics AG Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 3.55
Enterprise Value ($M) 3.55
Book Value ($M) 0.00
Book Value / Share 0.00
Price / Book n/a
NCAV ($M) 0.00
NCAV / Share 0.00
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -3.57
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio n/a
Current Ratio n/a

Balance Sheet (mrq) ($M)
Current Assets 0.00
Assets 0.00
Liabilities 0.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-21 13G/A Hafner Ronald 8.10
11-14 13G/A Lind Global Fund II LP 8.10 -97.59
11-14 13G Armistice Capital, Llc 9.99
11-04 13G/A YA II PN, Ltd. -100.00
11-04 13G/A Grisard Felix 2.80 -96.69
10-15 13G Alpha Capital Anstalt 9.99

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-04 31,086 196,924 15.79
2025-02-03 80,245 552,050 14.54
2025-01-31 11,036,014 30,494,736 36.19
2025-01-30 29,445 132,983 22.14

(click for more detail)

Similar Companies
NATR – Nature's Sunshine Products, Inc. NERV – Minerva Neurosciences, Inc.
NKTR – Nektar Therapeutics NRSN – NeuroSense Therapeutics Ltd.
NRXP – NRx Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io